Moderator - Hannelie Meyer, Professor in the School of Pharmacy and Head of the South African Vaccination and Immunisation Centre (SAVIC), Sefako Makgatho Health Sciences University, South Africa Co-moderator - Hanadi Alolimi, UNITWIN and Provision Coordinator, FIP, Netherlands Panellists: - Oluchukwu M
Developer competition : CagriSema (Novo Nordisk) versus retatrutide (Eli Lilly) represents the central competitive axis in next-generation obesity therapeutics
R.SureshS.DeviK.YadavS
Symptoms might include itching, rash, or hives
They can develop when there is too much pressure in this area, which often happens with constipation
Additional Uses Trulicity is also approved for reducing the risk of major cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease